These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8081281)
1. Does lipophosphoglycan enhance the T cell-stimulatory activity of lipophosphoglycan-associated proteins? Mendonça SC; De-Luca PM; Olafson RW; Jardim A; Coutinho SG Braz J Med Biol Res; 1994 Feb; 27(2):553-7. PubMed ID: 8081281 [TBL] [Abstract][Full Text] [Related]
2. Production of interferon-gamma and interleukin-4 by human T cells recognizing Leishmania lipophosphoglycan-associated protein. Kemp M; Kurtzhals JA; Christensen CB; Kharazmi A; Jardim A; Bendtzen K; Gachihi GS; Olafson RW; Theander TG Immunol Lett; 1993 Oct; 38(2):137-44. PubMed ID: 8294141 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63). Mendonça SC; Russell DG; Coutinho SG Clin Exp Immunol; 1991 Mar; 83(3):472-8. PubMed ID: 2004486 [TBL] [Abstract][Full Text] [Related]
4. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients. Kurtzhals JA; Hey AS; Jardim A; Kemp M; Schaefer KU; Odera EO; Christensen CB; Githure JI; Olafson RW; Theander TG Clin Exp Immunol; 1994 Jun; 96(3):416-21. PubMed ID: 8004810 [TBL] [Abstract][Full Text] [Related]
5. The Leishmania donovani lipophosphoglycan T lymphocyte-reactive component is a tightly associated protein complex. Jardim A; Tolson DL; Turco SJ; Pearson TW; Olafson RW J Immunol; 1991 Nov; 147(10):3538-44. PubMed ID: 1940354 [TBL] [Abstract][Full Text] [Related]
6. Activation of human T lymphocytes by Leishmania lipophosphoglycan. Kemp M; Theander TG; Handman E; Hey AS; Kurtzhals JA; Hviid L; Sørensen AL; Were JO; Koech DK; Kharazmi A Scand J Immunol; 1991 Feb; 33(2):219-24. PubMed ID: 1902000 [TBL] [Abstract][Full Text] [Related]
7. Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins. Russo DM; Turco SJ; Burns JM; Reed SG J Immunol; 1992 Jan; 148(1):202-7. PubMed ID: 1370169 [TBL] [Abstract][Full Text] [Related]
8. Distribution of lipophosphoglycan-associated epitopes in different Leishmania species and in African trypanosomes. Tolson DL; Schnur LF; Jardim A; Pearson TW Parasitol Res; 1994; 80(6):537-42. PubMed ID: 7528916 [TBL] [Abstract][Full Text] [Related]
9. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis. Rachamim N; Jaffe CL J Immunol; 1993 Mar; 150(6):2322-31. PubMed ID: 8450215 [TBL] [Abstract][Full Text] [Related]
10. Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi. Vinhas V; Freire M; Bacellar O; Cunha S; Rocha H; Carvalho EM Braz J Med Biol Res; 1994 May; 27(5):1199-205. PubMed ID: 8000341 [TBL] [Abstract][Full Text] [Related]
11. Vaccination of BALB/c mice with Leishmania donovani derived lipophosphoglycan does not conver cross-protection to L. major infections. Tonui WK East Afr Med J; 2003 May; 80(5):260-3. PubMed ID: 16167742 [TBL] [Abstract][Full Text] [Related]
12. Leishmania donovani-derived lipophosphoglycan plus BCG induces a Th1 type immune response but does not protect Syrian golden hamsters (Mesocricetus auratus) and BALB/c mice against Leishmania donovani. Tonui WK; Mpoke SS; Orago AS; Turco SJ; Mbati PA; Mkoji GM Onderstepoort J Vet Res; 2003 Dec; 70(4):255-63. PubMed ID: 14971728 [TBL] [Abstract][Full Text] [Related]
13. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice. Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953 [TBL] [Abstract][Full Text] [Related]
14. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum. Karp CL; Turco SJ; Sacks DL J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901 [TBL] [Abstract][Full Text] [Related]
16. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure. Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764 [TBL] [Abstract][Full Text] [Related]
17. Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages. Ibraim IC; de Assis RR; Pessoa NL; Campos MA; Melo MN; Turco SJ; Soares RP Parasit Vectors; 2013 Mar; 6():54. PubMed ID: 23497381 [TBL] [Abstract][Full Text] [Related]
18. Role of Leishmania donovani and its lipophosphoglycan in CD4+ T-cell activation-induced human immunodeficiency virus replication. Wolday D; Akuffo H; Demissie A; Britton S Infect Immun; 1999 Oct; 67(10):5258-64. PubMed ID: 10496904 [TBL] [Abstract][Full Text] [Related]
19. Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease. Gicheru MM; Olobo JO; Anjili CO Exp Parasitol; 1997 Feb; 85(2):109-16. PubMed ID: 9030661 [TBL] [Abstract][Full Text] [Related]
20. Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major. Moll H; Mitchell GF; McConville MJ; Handman E Infect Immun; 1989 Nov; 57(11):3349-56. PubMed ID: 2807527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]